PHYTOTHERAPY COMPOSITION ASSOCIATED WITH POLYVITAMIN AND MINERAL SUPPLEMENTS

Abstract

This invention relates to a phytotherapic composition associated to polyvitamin and mineral supplements in anti-inflammatory, antioxidant, immunostimulant treatments, as well as helping treatments of viral infections, musculoskeletal inflammatory disorders, and gastrointestinal disorders with lesions, in addition to microbiota alterations.

Claims

1. A phytotherapic composition, comprising: (i) Uncaria tomentosa present in the range of 42%-46% p.p; (ii) a vitamin complex, comprising vitamin A, vitamin C, vitamin D, and vitamin E, wherein vitamin A is present in the range of 0.03%-0.07% p.p., vitamin C is present in the range 30%-34% p.p., vitamin D is present in the range of 0.0028%-0.0035% p.p., and vitamin E is present in the range of 17%-21% p.p.; (iii) selenium present in the range of 0.017%-0.021% p.p.; (iv) zinc present in the range of 1%-5% p.p.; and (v) magnesium present in the range of 0.014%-0.018% p.p.; wherein each of the ranges for (i) to (v) is based on 100% of the total weight of the composition.

2. The phytotherapic composition according to claim 1 further defined as comprising: (i) 44.9% p.p. Uncaria tomentosa; (ii) a vitamin complex wherein 0.06% p.p. is vitamin A, 32% p.p. is vitamin C, 0.003% p.p. is vitamin D, 19% p.p. is vitamin E; (III) 0.02% p.p. is selenium; (iv) 3.8% p.p. is zinc; and (v) 0.017% p.p. is magnesium, wherein each of the ranges for (i) to (v) is based on 100% of the total weight of the composition.

3. The phytotherapic composition according to claim 1, wherein the composition is prepared in powder form, suitable for encapsulation and administration.

4. A method of treating viral infections, musculoskeletal inflammatory disorders, and/or gastrointestinal disorders with lesions, as well as microbiota alterations for patients, comprising: administering a composition as defined by claim 1 to a patient.

Description

DETAILED DESCRIPTION OF THIS INVENTION

[0026] This invention describes a phytotherapic composition associated to polyvitamin and mineral supplements comprising (i) Uncaria tomentosa; (ii) choline; (iii) a vitamin complex, comprising vitamin A, vitamin B6, vitamin C, vitamin D, vitamin E, vitamin B1 and vitamin B12; (iv) selenium; (v) zinc; and (vi) magnesium, wherein: (i) Uncaria tomentosa is present in the range of 16%-20% p.p.; (ii) choline is present in the range of 19%-23% p.p; (iii) vitamin A is present in the range of 0.25%-0.65% p.p., vitamin B6 is present in the range of 0.19%-0.23% p.p., vitamin C is present in the range of 41%-45% p.p., vitamin D is present in the range of 0.001%-0.003% p.p., vitamin E is present in the range of 11%-15% p.p., vitamin B1 is present in the range of 0.11%-0.15% p.p., and vitamin B12 is present in the range of 0.0002%-0.0004% p.p.; (iv) selenium is present in the range of 0.011%-0.015% p.p.; (v) zinc is present in the range of 1%-3% p.p.; and (vi) magnesium is present in the range of 0.009%-0.013% p.p., with the range based on 100% of the total weight of the composition.

[0027] Preferably this invention describes a phytotherapic composition associated to polyvitamin and mineral supplements comprising (i) 18.5% p.p. Uncaria tomentosa; (ii) 21.7% p.p. choline; 0.45% p.p. is vitamin A, 0.21% p.p. is vitamin B6, 43.7% p.p. p.p. is vitamin C, 0.002% p.p. is vitamin D, 13% p.p. is vitamin E, 0.13% p.p. is vitamin B1, 0.0003% p.p. is vitamin B12; (iv) 0.013% p.p. of selenium; (v) 2.4% p.p. of zinc; and (vi) 0.01% p.p. of magnesium, with the range based on 100% of the total weight of the composition.

[0028] The phytotherapic composition associated to polyvitamin and mineral supplements addressed by this invention is prepared in powder form, suitable for encapsulation and oral administration.

[0029] This invention also provides for the use of the phytotherapic composition associated to polyvitamin and mineral supplements as defined above, in the preparation of an anti-inflammatory, antioxidant, and immunostimulant supplement to help with the treatment of viral infections, musculoskeletal inflammatory disorders and gastrointestinal disorders with lesions, as well as microbiota alterations.